Prediction of drug-protein binding is critical for virtual drug screening. Many deep learning methods have been proposed to predict the drug-protein binding based on protein sequences and drug representation sequences. However, most existing methods extract features from protein and drug sequences separately. As a result, they can not learn the features characterizing the drug-protein interactions. In addition, the existing methods encode the protein (drug) sequence usually based on the assumption that each amino acid (atom) has the same contribution to the binding, ignoring different impacts of different amino acids (atoms) on the binding. However, the event of drug-protein binding usually occurs between conserved residue fragments in the protein sequence and atom fragments of the drug molecule. Therefore, a more comprehensive encoding strategy is required to extract information from the conserved fragments.
In this paper, we propose a novel model, named FragDPI, to predict the drug-protein binding affinity. Unlike other methods, we encode the sequences based on the conserved fragments and encode the protein and drug into a unified vector. Moreover, we adopt a novel two-step training strategy to train FragDPI. The pre-training step is to learn the interactions between different fragments using unsupervised learning. The fine-tuning step is for predicting the binding affinities using supervised learning. The experiment results have illustrated the superiority of FragDPI.
. [J]. Frontiers of Computer Science, 2023, 17(5): 175903.
Zhihui YANG, Juan LIU, Xuekai ZHU, Feng YANG, Qiang ZHANG, Hayat Ali SHAH. FragDPI: a novel drug-protein interaction prediction model based on fragment understanding and unified coding. Front. Comput. Sci., 2023, 17(5): 175903.
D C, Swinney J Anthony . How were new medicines discovered? Nature Reviews Drug Discovery, 2011, 10(7): 507–519
2
S, Gupta A, Jadaun H, Kumar U, Raj P K, Varadwaj A R Rao . Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study. Journal of Biomolecular Structure and Dynamics, 2015, 33( 11): 2421–2441
3
E, Yuriev M, Agostino P A Ramsland . Challenges and advances in computational docking: 2009 in review. Journal of Molecular Recognition, 2011, 24( 2): 149–164
4
K, Huang T, Fu L M, Glass M, Zitnik C, Xiao J Sun . DeepPurpose: a deep learning library for drug-target interaction prediction. Bioinformatics, 2020, 36(22−23): 5545−5547
5
K, Huang C, Xiao L M, Glass J Sun . MolTrans: molecular interaction transformer for drug-target interaction prediction. Bioinformatics, 2021, 37( 6): 830–836
6
Q, Zhao F, Xiao M, Yang Y, Li J Wang . AttentionDTA: prediction of drug−target binding affinity using attention model. In: Proceedings of 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 2019, 64−69
7
Z, Liao R, You X, Huang X, Yao T, Huang S Zhu . DeepDock: enhancing ligand-protein interaction prediction by a combination of ligand and structure information. In: Proceedings of 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 2019, 311−317
8
F, Bai F, Morcos R R, Cheng H, Jiang J N Onuchic . Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113( 50): E8051–E8058
9
H, Yao Y, Song Y, Chen N, Wu J, Xu C, Sun J, Zhang T, Weng Z, Zhang Z, Wu L, Cheng D, Shi X, Lu J, Lei M, Crispin Y, Shi L, Li S Li . Molecular architecture of the SARS-CoV-2 virus. Cell, 2020, 183( 3): 730–738.e13
10
X, Shu A, Royant M Z, Lin T A, Aguilera V, Lev-Ram P A, Steinbach R Y Tsien . Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science, 2009, 324( 5928): 804–807
11
T, Pahikkala A, Airola S, Pietila S, Shakyawar A, Szwajda J, Tang T Aittokallio . Toward more realistic drug-target interaction predictions. Briefings in Bioinformatics, 2015, 16( 2): 325–337
12
X, Zheng H, Ding H, Mamitsuka S Zhu . Collaborative matrix factorization with multiple similarities for predicting drug-target interactions. In: Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2013, 1025−1033
13
H, Özturk A, Özgür E Ozkirimli . DeepDTA: deep drug-target binding affinity prediction. Bioinformatics, 2018, 34( 17): i821–i829
14
T, Nguyen H, Le S Venkatesh . GraphDTA: prediction of drug−target binding affinity using graph convolutional networks. BioRxiv, 2019, 684662 https://doi.org/10.1101/684662
15
J, Devlin M W, Chang K, Lee K Toutanova . BERT: pre-training of deep bidirectional transformers for language understanding. In: Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies. 2019, 4171−4186
16
L, Dong N, Yang W, Wang F, Wei X, Liu Y, Wang J, Gao M, Zhou H W Hon . Unified language model pre-training for natural language understanding and generation. In: Proceedings of the 33rd International Conference on Neural Information Processing Systems. 2019, 1170
17
Radford A, Wu J, Child R, Luan D, Amodei D, Sutskever I. Language models are unsupervised multitask learners. OpenAI blog, 2019, 1(8): 9
18
C, Raffel N, Shazeer A, Roberts K, Lee S, Narang M, Matena Y, Zhou W, Li P J Liu . Exploring the limits of transfer learning with a unified text-to-text transformer. Journal of Machine Learning Research, 2020, 21: 1–67
19
A, Vaswani N, Shazeer N, Parmar J, Uszkoreit L, Jones A N, Gomez Ł, Kaiser I Polosukhin . Attention is all you need. In: Proceedings of the 31st International Conference on Neural Information Processing Systems. 2017, 6000−6010
20
M, Karimi D, Wu Z, Wang Y Shen . DeepAffinity: interpretable deep learning of compound−protein affinity through unified recurrent and convolutional neural networks. Bioinformatics, 2019, 35( 18): 3329–3338
21
T, Liu Y, Lin X, Wen R N, Jorissen M K Gilson . BindingDB: a web-accessible database of experimentally determined protein−ligand binding affinities. Nucleic Acids Research, 2007, 35( S1): D198–D201
22
M, Kuhn Mering C, Von M, Campillos L J, Jensen P Bork . STITCH: interaction networks of chemicals and proteins. Nucleic Acids Research, 2008, 36( S1): D684–D688
23
B E, Suzek Y, Wang H, Huang P B, McGarvey C H, Wu Consortium UniProt . UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics, 2015, 31( 6): 926–932
24
M, Li Z, Lu Y, Wu Y Li . BACPI: a bi-directional attention neural network for compound−protein interaction and binding affinity prediction. Bioinformatics, 2022, 38( 7): 1995–2002
25
T A, Leonard B, Różycki L F, Saidi G, Hummer J H Hurley . Crystal structure and allosteric activation of protein kinase C βII. Cell, 2011, 144( 1): 55–66
26
R B, Sutton S R Sprang . Structure of the protein kinase cβ phospholipid-binding C2 domain complexed with Ca2+. Structure, 1998, 6( 11): 1395–1405
27
T T N, Thao F, Labroussaa N, Ebert P, V’kovski H, Stalder J, Portmann J, Kelly S, Steiner M, Holwerda A, Kratzel M, Gultom K, Schmied L, Laloli L, Hüsser M, Wider S, Pfaender D, Hirt V, Cippà S, Crespo-Pomar S, Schröder D, Muth D, Niemeyer V M, Corman M A, Müller C, Drosten R, Dijkman J, Jores V Thiel . Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 2020, 582( 7813): 561–565
28
N, Tzenaki E A Papakonstanti . p110δ PI3 kinase pathway: emerging roles in cancer. Frontiers in Oncology, 2013, 3: 40
29
Y, Takahashi A, Hayakawa R, Sano H, Fukuda M, Harada R, Kubo T, Okawa Y Kominato . Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19. Scientific Reports, 2021, 11( 1): 3379
30
H P, Volz C H Gleiter . Monoamine oxidase inhibitors. Drugs & Aging, 1998, 13( 5): 341–355
31
A, Kumar J, Redondo-Muñoz V, Perez-García I, Cortes M, Chagoyen A C Carrera . Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival. Molecular and Cellular Biology, 2011, 31( 10): 2122–2133
